LRRK2 and Parkinson disease: The present study utilized eight human iPSC lines (Figure S1A, Supporting Information) from which human neuroepithelial stem cell lines (hNESCs) were derived according to published protocols.16 We used hNESC lines from two PD patients carrying the LRRK2‐G2019S mutation and from two healthy individuals.